Cited by 28Retinal Development and DisordersRetinal Diseases and TreatmentsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; the references it cites are not checked yet.

Long-term follow-up of a family with dominant X-linked retinitis pigmentosa

Open access

Abstract

Purpose To document the progression of disease in male and female members of a previously described family with X-linked dominant retinitis pigmentosa (RP) caused by a de novo insertion after nucleotide 173 in exon ORF15 of RPGR.Methods The clinical records of 19 members of family UTAD054 were reviewed. Their evaluations consisted of confirmation of family history, standardised electroretinograms (ERGs), Goldmann visual fields, and periodic ophthalmological examinations over a 23-year period.Results Male members of family UTAD054 had non-recordable to barely recordable ERGs from early childhood. The males showed contracted central fields and developed more severe retinopathy than the females. The female members showed a disease onset delayed to teenage years, recordable but diminishing photopic and scotopic ERG amplitudes in a cone-rod pattern, progressive loss and often asymmetric visual fields, and diffuse atrophic retinopathy with fewer pigment deposits compared with males.Conclusions This insertion mutation in the RPGR exon ORF15 is associated with a RP phenotype that severely affects males early and females by 30 years of age, and is highly penetrant in female members. Families with dominant-acting RPGR mutations may be mistaken to have an autosomal mode of inheritance resulting in an incorrect prediction of recurrence risk and prognosis. Broader recognition of X-linked RP forms with dominant inheritance is necessary to facilitate appropriate counselling of these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/eye.2009.270

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The size of the transgene that can be packaged into AAV capsids is limited to less than 5 kb.

    “Additional disadvantages include the limited size of the transgene (<5 kb) that can be packaged into AAV capsids [78].”

    From The Ocular Gene Delivery Landscape (2021) · cites this paper as [78]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 38 · Cited by 28

Research works printed but not linked: 1

  1. McGuire RE, Sullivan LS, Blanton SH, Church MW, Heckenlively JR, Daiger SP . X-linked dominant cone-rod degeneration: linkage mapping of a new locus for retinitis pigmentosa (RP 15) to Xp22.13-p22.11. Am J Hum Genet 1995; 57 (1): 87–94.

Metadata

Authors
Wu, D. M., Khanna, H., Atmaca-Sonmez, P., Sieving, P. A., Branham, K., Othman, M., Swaroop, A., Daiger, S. P., & Heckenlively, J. R.
Affiliations
  • University of Michigan (US)
  • National Eye Institute (US)
  • The University of Texas Health Science Center at Houston (US)
Corresponding author
Heckenlively, J R
Venue
Eye
Published
2009-11-06
Volume
24
Issue
5
Pages
764-774
ISSN
  • 0078-5334 (ISSN-L)
  • 0950-222X
  • 1476-5454
OpenAlex
W2029864944
Cited by
28
References
38
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 5 · 2013: 2 · 2012: 2
FWCI
0.27
Type
journal article
Language
en
Open access
Locations
  • Eye (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Eye Institute (EY-007961, R01EY007142, R01EY007961)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords
RPGR, de novo mutations, disease progression, electroretinogram, visual field defects, family follow-up
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Dark Adaptation, Electroretinography, Exons, Eye Proteins, Female, Follow-Up Studies, Humans, Infant, Male, Middle Aged, Refractive Errors, Retinitis Pigmentosa, Sensory Thresholds, Visual Acuity, Visual Fields, Mutagenesis, Insertional, Age of Onset, Disease Progression, Genetic Diseases, X-Linked, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review